ZVRA
Zevra Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss +7.5% · neue Nettopositionen 0.0% — Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q2 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 73 | +6 | 29.05M | $415.89M | +12 | −6 |
| Q1 2026 | 69 | 0 | 26.10M | $242.75M | +4 | −4 |
| Q4 2025 | 68 | +1 | 25.36M | $227.23M | +1 | — |
| Q3 2025 | 16 | +2 | 19.14M | $181.99M | +2 | — |
| Q2 2025 | 11 | 0 | 17.09M | $150.53M | — | — |
| Q1 2025 | 8 | 0 | 6.58M | $49.25M | +1 | −1 |
| Q4 2024 | 8 | +1 | 6.30M | $52.58M | +2 | −1 |
| Q3 2024 | 6 | +2 | 1.92M | $13.36M | +3 | −1 |
| Q2 2024 | 4 | — | 1.15M | $5.62M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 4.17M | +15.2% | $36.72M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 2 | BlackRock ✦ (passiv) | 4.08M | — | $35.96M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passiv) | 4.08M | — | $35.96M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passiv) | 4.08M | — | $35.96M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passiv) | 4.08M | — | $35.96M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passiv) | 4.08M | — | $35.96M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passiv) | 4.08M | — | $35.96M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passiv) | 4.08M | — | $35.96M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passiv) | 4.08M | — | $35.96M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | The Vanguard Group ✦ (passiv) | 2.95M | — | $26.01M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | The Vanguard Group ✦ (passiv) | 2.95M | — | $26.01M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (passiv) | 2.95M | — | $26.01M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Fidelity (FMR) ✦ | 2.29M | — | $20.17M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Fidelity (FMR) ✦ | 2.29M | — | $20.17M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Fidelity (FMR) ✦ | 2.29M | — | $20.17M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Geode Capital Management ✦ (passiv) | 1.24M | +0.8% | $10.95M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 17 | Geode Capital Management ✦ (passiv) | 1.24M | +0.8% | $10.95M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 18 | State Street Global Advisors ✦ (passiv) | 1.24M | +5.5% | $10.94M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Millennium Management ✦ | 634.82K | +484.0% | $5.59M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 189.31K | +591.7% | $1.67M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 189.31K | +591.7% | $1.67M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Wellington Management ✦ | 146.28K | +4.2% | $1.29M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | Wellington Management ✦ | 146.28K | +4.2% | $1.29M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | Wellington Management ✦ | 146.28K | +4.2% | $1.29M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 25 | Citadel Advisors ✦ | 114.27K | -54.1% | $1.01M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 26 | Citadel Advisors ✦ | 114.27K | -54.1% | $1.01M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 27 | T. Rowe Price ✦ | 25.69K | +13.2% | $227,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 147 Inhaber, 40.93M Anteile, $378.34M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.